Revelation Biosciences, Inc. (REVB)
1.01
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 11:22
Revelation Biosciences Price : 1.01 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 1.00 | 1.04 | 1.00 | 1.01 | 16010.00 |
| Sep 04, 2026 | 1.015 | 1.04 | 0.99 | 1.01 | 7735.00 |
| Sep 03, 2026 | 1.03 | 1.04 | 0.99 | 1.01 | 19959.00 |
| Sep 02, 2026 | 0.99 | 1.04 | 0.99 | 1.00 | 17999.00 |
| Sep 01, 2026 | 1.011 | 1.033 | 0.9823 | 0.9866 | 25217.00 |
| Aug 31, 2026 | 1.06 | 1.06 | 1.00 | 1.00 | 12894.00 |
| Aug 28, 2026 | 1.04 | 1.08 | 1.000 | 1.05 | 20307.00 |
| Aug 27, 2026 | 0.9718 | 1.03 | 0.9552 | 1.03 | 20973.00 |
| Aug 26, 2026 | 0.9801 | 1.01 | 0.95 | 0.955 | 36579.00 |
| Aug 25, 2026 | 1.09 | 1.10 | 0.91 | 1.00 | 200063.0 |
| Aug 24, 2026 | 1.10 | 1.12 | 1.060 | 1.10 | 49709.00 |
| Aug 21, 2026 | 1.10 | 1.10 | 1.06 | 1.09 | 9055.00 |
| Aug 20, 2026 | 1.12 | 1.14 | 1.07 | 1.07 | 22179.00 |
| Aug 19, 2026 | 1.16 | 1.20 | 1.09 | 1.11 | 166466.0 |
| Aug 18, 2026 | 1.145 | 1.16 | 1.07 | 1.11 | 75989.00 |
| Aug 17, 2026 | 1.09 | 1.15 | 1.05 | 1.15 | 66936.00 |
| Aug 14, 2026 | 1.14 | 1.14 | 1.034 | 1.049 | 31385.00 |
| Aug 13, 2026 | 1.11 | 1.12 | 1.10 | 1.11 | 8084.00 |
| Aug 12, 2026 | 1.10 | 1.125 | 1.10 | 1.11 | 4617.00 |
| Aug 11, 2026 | 1.145 | 1.145 | 1.10 | 1.13 | 15218.00 |
| Aug 10, 2026 | 1.18 | 1.217 | 1.12 | 1.13 | 34529.00 |
| Aug 07, 2026 | 1.03 | 1.20 | 1.03 | 1.14 | 25573.00 |
| Aug 06, 2026 | 1.13 | 1.152 | 1.12 | 1.12 | 6055.00 |
| Aug 05, 2026 | 1.14 | 1.180 | 1.125 | 1.15 | 22675.00 |
| Aug 04, 2026 | 1.07 | 1.15 | 1.045 | 1.13 | 33683.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | 3.50 |
| ACADIA Pharmaceuticals, Inc. | 27.87 |
| Agenus, Inc. | 7.16 |
| Alnylam Pharmaceuticals, Inc. | 256.17 |
| Amgen, Inc. | 392.97 |
Price Related Metrics
| Price to Book Value | 0.3921 |
| Earnings Yield | -1.22K% |
| Market Cap | 3.948M |